Skip to main content

Polymyxin B News

Related terms: Polymyxin B Ophthalmic, Polymyxin B Topical

FDA Medwatch Alert: AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate Matter

January 26, 2022 – East Windsor, New Jersey, AuroMedics Pharma LLC has initiated a voluntary recall of lot number CPB200013 of Polymyxin B for Injection USP, 500,000 Units/Vial, to the consumer level ...

FDA Medwatch Alert: Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles

ISSUE: Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Polymyxin B patient information at Drugs.com